Therefore, this multiple-site investigation offers strong evidence demonstrating TRPM3 as a potential biomarker for the diagnosis of ME/CFS, given the accumulating evidence. This evidence concerns the gene TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome.